- Language: English
- 633 Pages
- Published: December 2013
- Region: Global
Global Proteomics Market 2012-2016
- Published: April 2013
- Region: Global
- 44 pages
- Infiniti Research Limited
TechNavio's analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the growth of this market.
TechNavio's report, Global Proteomics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Proteomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp.
The other vendors mentioned in the report are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., and Bruker Daltonics Inc.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of each of these key vendors? SHOW LESS READ MORE >
1. Executive Summary
2. List of Abbreviations
4. Market Research Methodology
Market Research Process
5. Scope of the Report
6. Market Landscape
6.1. Market Size and Forecast
6.2. Market Segmentation
6.3. Five Force Analysis
7. Geographical Segmentation
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1. Thermo Fischer Scientific Inc.
15.1.1. Business Overview
15.1.2. Key Information
15.1.3. SWOT Analysis
15.2. Agilent Technologies Inc.
15.2.1. Business Overview
15.2.2. Business Segmentation
15.2.3. Key Information
15.2.4. SWOT Analysis
15.3. Life Technologies Corp.
15.3.1. Business Overview
15.3.2. Key Information
15.3.3. SWOT Analysis
15.4. Danaher Corp.
15.4.1. Business Overview
15.4.2. Business Segmentation
15.4.3. Key Information
15.4.4. SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Proteomics Market 2012-2016 (US$ billion)
Exhibit 3: Global Proteomics Market Segmentation
Exhibit 4: Global Proteomics Market Segmentation 2012
Exhibit 5: Global Proteomics Market by Geographical Segmentation 2012
Exhibit 6: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 7: Business Segmentation of Agilent Technologies Inc.
Exhibit 8: Business Segmentation of Life Technologies Corp.
Exhibit 9: Business Segmentation of Danaher Corp.
TechNavio Announces the Publication of its Research Report - Global Proteomics Market 2012-2016
TechNavio recognizes the following companies as the key players in the Global Proteomics Market: Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''One of the recent trends being witnessed in the Global Proteomics market is the growing popularity of proteomic analysis as compared to genomic analysis. Both genomics and proteomics find application in drug discovery, disease diagnosis, and drug development. Genomics is the study of the genes or DNA of an organism. Proteomics, which was introduced after genomics, has become more popular because it offers more benefits than genomics. For instance, proteomic analysis is faster and more effective in terms of data analysis than genomic analysis. Thus, there is a considerable shift from genomics to proteomics for disease diagnosis and drug development. This trend augers well for the growth of the Global Proteomics market during the forecast period.''
According to the report, one of the main drivers in this market is the increasing demand for personalized medicines. The study and identification of defective proteins is required for the development of personalized medicines, which in turn is propelling the growth of the market.
Further, the report states that one of the major challenges in this market is the intense competition among vendors, which has resulted in severe pricing pressure. As a result of the prevalent intense competition, the leading vendors in the market are currently witnessing low profit margins.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., Bruker Daltonics Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Thermo Fischer Scientific Inc.
- Agilent Technologies Inc.
- Life Technologies Corp.
- and Danaher Corp.
- Sigma-Aldrich Corp.
- Roche Diagnostics Corp.
- Betcon Dickinson and Co.
- Affymetrix Inc.
- Shimadzu Corp.
- Bio Rad Laboratories Inc.
- Illumina Inc.
- Abbott Laboratories
- GE Healthcare Ltd.
- Perkin Elmer Inc.
- Xencor Inc.
- Cellzome AG
- Waters Corp.
- Dionex Corp.
- Bruker Daltonics Inc.